D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$453M |
| 2 |
Oracle
ORCL
|
+$431M |
| 3 |
Apple
AAPL
|
+$376M |
| 4 |
SLB Ltd
SLB
|
+$353M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$746M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
NVIDIA
NVDA
|
+$348M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$307M |
| 5 |
AT&T
T
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 11.63% |
| 3 | Healthcare | 11.01% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Camtek
CAMT
$6.9B
| $151K | ﹤0.01% |
+22,322
| New | +$173K |
|
3552
PUT
JELD-WEN Holding
JELD
$94.8M
| $151K | ﹤0.01% |
+10,600
| New | +$188K |
|
|
CAMP
3553
DELISTED
CalAmp Corp.
CAMP
| $151K | ﹤0.01% |
506
-1,498
| -75% | -$622K |
|
|
ACGN
3554
DELISTED
Aceragen Inc
ACGN
| $149K | ﹤0.01% |
3,173
+586
| +23% | +$67.4K |
|
|
NGD
3555
DELISTED
New Gold Inc
NGD
| $148K | ﹤0.01% |
191,714
+118,963
| +164% | +$96.1K |
|
3556
SIGA Technologies
SIGA
$223M
| $146K | ﹤0.01% |
+18,460
| New | +$106K |
|
|
VIA
3557
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $145K | ﹤0.01% |
+3,907
| New | +$162K |
|
|
PDS
3558
Precision Drilling
PDS
$1.09B
| $144K | ﹤0.01% |
4,132
+3,389
| +456% | +$168K |
|
|
DERM
3559
DELISTED
Dermira, Inc.
DERM
| $144K | ﹤0.01% |
+20,079
| New | +$220K |
|
|
AVH
3560
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $143K | ﹤0.01% |
35,313
+24,664
| +232% | +$125K |
|
|
FPRX
3561
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $140K | ﹤0.01% |
+15,043
| New | +$179K |
|
|
FTR
3562
DELISTED
Frontier Communications Corp.
FTR
| $139K | ﹤0.01% |
58,474
-9,885
| -14% | -$41.9K |
|
|
BVH
3563
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $138K | ﹤0.01% |
4,833
-277
| -5% | -$8.53K |
|
|
BBBY
3564
Bed Bath & Beyond
BBBY
$473M
| $137K | ﹤0.01% |
13,414
+1,108
| +9% | +$16.6K |
|
|
AXDX
3565
DELISTED
Accelerate Diagnostics
AXDX
| $136K | ﹤0.01% |
1,180
-3,706
| -76% | -$549K |
|
3566
Talphera
TLPH
$70.1M
| $135K | ﹤0.01% |
2,916
-6,106
| -68% | -$409K |
|
|
FRED
3567
DELISTED
Fred's Inc
FRED
| $135K | ﹤0.01% |
+71,392
| New | +$185K |
|
|
PVLA
3568
Palvella Therapeutics
PVLA
$1.98B
| $133K | ﹤0.01% |
624
+323
| +107% | +$100K |
|
3569
Protagonist Therapeutics
PTGX
$8.75B
| $132K | ﹤0.01% |
19,645
+8,450
| +75% | +$67K |
|
3570
CALL
Insmed
INSM
$23.2B
| $131K | ﹤0.01% |
10,000
| – | – |
|
3571
Barnes & Noble Education
BNED
$412M
| $126K | ﹤0.01% |
313
-580
| -65% | -$323K |
|
3572
ProPetro Holding
PUMP
$1.45B
| $126K | ﹤0.01% |
+10,192
| New | +$168K |
|
3573
Nabors Industries
NBR
$1.23B
| $125K | ﹤0.01% |
1,254
-16
| -1% | -$3.52K |
|
3574
Lifecore Biomedical
LFCR
$162M
| $123K | ﹤0.01% |
10,420
-11,689
| -53% | -$161K |
|
3575
AudioCodes
AUDC
$244M
| $121K | ﹤0.01% |
+12,211
| New | +$131K |
|
Similar funds
D.E. Shaw & Co's Q4 2018 Portfolio in Review
As of Q4 2018, D.E. Shaw & Co held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
D.E. Shaw & Co deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.
- D.E. Shaw & Co's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
- D.E. Shaw & Co added most to Oracle in Q4 2018, an estimated $431M increase.
- D.E. Shaw & Co's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
- D.E. Shaw & Co fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
- D.E. Shaw & Co's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
- D.E. Shaw & Co opened 541 new positions and closed 497 in Q4 2018.
- D.E. Shaw & Co's portfolio value fell 13% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.